Anticitrullinated Protein Antibodies Induce Inflammatory Gene Expression Profile in Peripheral Blood Cells from CCP–positive Patients with RA
Authors:
- Smadar GertelSGSmadar Gertel
- Gidi KarmonGKGidi Karmon
- Eszter SzarkaESEszter Szarka
- Ora ShovmanOSOra Shovman
- Esther Houri-LeviEHEsther Houri-Levi
- Edna MozesEMEdna Mozes
- Yehuda ShoenfeldYSYehuda Shoenfeld
- Howard AmitalHAHoward Amital
Open Access
- 15 January 2018
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 45 (3) , 310-319
Abstract
Objective.: Anticitrullinated protein antibodies (ACPA) have major diagnostic significance in rheumatoid arthritis (RA). ACPA are directed against different citrullinated antigens, including filaggrin, fibrinogen, vimentin, and collagen. The presence of ACPA is associated with joint damage and extraarticular manifestations, suggesting that ACPA may have a significant role in the pathogenesis of RA.Methods.: To verify the effect of ACPA on RA-immune cells, peripheral blood mononuclear cells (PBMC) from cyclic citrullinated peptide (CCP)–positive patients with RA and healthy controls were coculturedin vitrowith ACPA. ACPA-positive stained cells were analyzed by flow cytometry and the effect of ACPA on mRNA expression levels was evaluated by real-time PCR. We tested whether the stimulatory effects induced by ACPA could be inhibited by the addition of a new multiepitope citrullinated peptide (Cit-ME).Results.: We found that ACPA bind specifically to PBMC from CCP-positive patients with RA through the Fab portion. ACPA induce upregulation of pathogenic cytokine expression (4- to 13-fold increase) in PBMC derived from CCP-positive patients with RA. Moreover, ACPA upregulated IL-1β and IL-6 mRNA expression levels by 10- and 6-fold, respectively, compared to control IgG. Cit-ME, a genuine ligand of ACPA, inhibited the ACPA-induced upregulation of IL-1β and IL-6 by 30%.Conclusion.: ACPA bind to a limited percentage of PBMC and upregulate inflammatory cytokine expression, suggesting that ACPA is involved in RA pathogenesis. Targeting ACPA to decrease their pathogenic effects might provide a novel direction in developing therapeutic strategies for RA.Keywords
This publication has 50 references indexed in Scilit:
- Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritisClinical and Experimental Immunology, 2013
- T cell responses to citrullinated self-peptides in patients with rheumatoid arthritisRheumatology International, 2013
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentinJournal of Clinical Investigation, 2012
- The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restrictedJournal of Autoimmunity, 2011
- Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteinsAnnals of the Rheumatic Diseases, 2011
- Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritisJournal of Experimental Medicine, 2009
- The differential expressions of 78-kDa glucose-regulated protein of infiltrating plasma cells in peripheral joints with the histopathological variants of rheumatoid synovitisArthritis Research & Therapy, 2009
- Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewAnnals of the Rheumatic Diseases, 2006
- Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritisJournal of Clinical Investigation, 2006
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987